108781-14-2

Basic information

• Product Name: Benzaldehyde, 3-[(4-methoxyphenyl)methoxy]-
• CAS NO: 108781-14-2
• Molecular Formula: C15H14O3
• Molecular Weight: 242.274
• Mol File: 108781-14-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 3-[(4-methoxyphenyl)methoxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3-[(4-methoxyphenyl)methoxy]-(108781-14-2)
• EPA Substance Registry System: Benzaldehyde, 3-[(4-methoxyphenyl)methoxy]-(108781-14-2)

Safety Data

• Hazardous Substances Data: 108781-14-2(Hazardous Substances Data)

Upstream product

• 100-83-4 meta-hydroxybenzaldehyde 
• 824-94-2 p-methoxybenzyl chloride 

Downstream Products

• 108781-15-3 3-(p-methoxybenzyloxy)benzylidenemalonic acid diethyl ester 
• 1236355-45-5 2-methylthio-(E,E)-4,6-bis-(3'-hydroxystyryl)pyrimidine 
• 1396037-16-3 2-methylthio-(E,E)-4,6-bis[3'-(4''-methoxybenzyloxy)styryl]pyrimidine 
• 1236355-39-7 2-methoxy-(E,E)-4,6-bis-(3'-hydroxystyryl)pyrimidine 
• 1396036-85-3 2-methoxy-(E,E)-4,6-bis[3'-(4''-methoxybenzyloxy)styryl]pyrimidine 
• 1396036-57-9 (E,E)-4,6-bis[3'-(4''-methoxybenzyloxy)styryl]pyrimidine 
• 209120-06-9 {1-Fluoro-2-[3-(4-methoxy-benzyloxy)-phenyl]-ethyl}-phosphonic acid diethyl ester 
• 209120-15-0 [1-Fluoro-2-(3-hydroxy-phenyl)-ethyl]-phosphonic acid diethyl ester 
• 336193-99-8 3-(4-Methoxybenzyloxy)benzonitrile 
• 104-21-2 p-methoxybenzyl acetate 
• 100-83-4 meta-hydroxybenzaldehyde 

Relevant articles and documents

INHIBITORS OF ANTIGEN PRESENTATION BY HLA-DR

Chromanone compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with the inhibition of antigen presentation by HLA-DR.

Irreversible dopamine-β-hydroxylase inhibitors

Potent, irreversible dopamine-β-hydroxylase inhibitors having the Formula: STR1 which are useful to inhibit dopamine-β-hydroxylase activity, pharmaceutical compositions including these inhibitors or 2-cyano-2-phenethylamine, and methods of using these inhibitors or 2-cyano-2-phenethylamine to inhibit dopamine-β-hydroxylase activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented inhibitors.